title: Anti-Leu2a (anti-CD8) monoclonal antibody therapy: antibody-mediated cell clearance in vivo requires Fc-FcRII interaction.
authors.affiliation: Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston 02114.
authors.forename: S L
authors.initials: SL
authors.lastname: Wee
authors.forename: J M
authors.initials: JM
authors.lastname: Phelan
authors.forename: F I
authors.initials: FI
authors.lastname: Preffer
authors.forename: R B
authors.initials: RB
authors.lastname: Colvin
authors.forename: A B
authors.initials: AB
authors.lastname: Cosimi
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D016827:CD8 Antigens; D006084:Graft Rejection; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D016030:Kidney Transplantation; D011961:Receptors, Fc / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D016827:CD8 Antigens; D007074:Immunoglobulin G; D011961:Receptors, Fc